Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Cassava to stop trials of Alzheimer's drug after late-stage study failure
(Reuters) -Cassava Sciences said on Monday it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, sending shares of the drug developer plummeting more than 80% before the bell.
Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops
Cassava Sciences stock plummeted Monday after the company's Alzheimer's treatment failed in Phase 3 testing. Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher,
Cassava Sciences Stock Slides 84% as Alzheimer’s Trial Fails
Cassava Sciences stock collapsed after an Alzheimer’s drug the company was testing failed to significantly help participants in a clinical trial. The stock plummeted 84% to $4.15 Monday after reporting that a Phase 3 trial meant to demonstrate the efficacy of a medication called Simufilam fell short of key milestones.
Cassava shares sink on plans to stop Alzheimer's drug studies
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, sending shares of the drug developer plummeting 83% in early trading on Monday.
Cassava Stock Plunges as Alzheimer's Drug Fails Late-Stage Study
KEY TAKEAWAYS Cassava Sciences shares are plunging in premarket trading and are losing most of their value after the biotech firm said its experimental Simufilam drug aimed at treating Alzheimer’s disease failed a late-stage study.
Searching for missing Georgians with Alzheimer’s during holidays
A Georgia man is training law enforcement agencies on how to find lost residents living with Alzheimer’s and dementia.
News Medical32m
Research shows "Alzheimer's in a dish" model can accelerate drug discovery
A decade ago, researchers introduced a new model for studying Alzheimer's disease. Known as "Alzheimer's in a dish," the model uses cultures of mature brain cells suspended in a gel to recapitulate ...
OpenLIne - Alzheimer's Awareness - p4
Psychologist Corey Bolton and nurse practitioner Ray Romano join this edition of OpenLine to share why it's important to make ...
KSTP-TV2h
Police searching for missing man with Alzheimer’s in St. Paul
Renard Halliburton was reported missing from his home in the 1500 block of Conway Street early afternoon on Wednesday.
Cassava's Alzheimer's drug fails in late-stage study
(Reuters) -Cassava Sciences on Monday said its experimental Alzheimer's disease drug did not meet the main or secondary goals ...
Alzheimer's awareness: 10 early warning signs, 10 healthy habits
Stay alert with list of early signs and symptoms of dementia that disrupts daily life and may be a symptom of Alzheimer’s or ...
Alector: Bleak Prospects After Alzheimer's Failure
Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...
Psychology Today1d
The Relationship Between Music and Alzheimer’s Disease
Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...
Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
IGC Pharma, Inc. reported additional interim data from its clinical trial evaluating IGC-AD1 for agitation in Alzheimer’s.
McKnight's Senior Living20h
California notes progress in Alzheimer’s support plans, looks toward dementia-capable continuum of care
Guided by the Alzheimer's Disease Prevention and Preparedness Task Force, California has taken “significant” action and made ...
Hosted on MSN1d
Alzheimer's Trials Fail; Blood Test Predicts Tau; Neuroscience Moves to Bluesky
Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...